Mr. Palay is one of our founders and has served as Chairman of the Board and as Chief Executive Officer since 2007.  Mr. Palay previously served as chairman of the board and chief executive officer of each of our predecessors from their founding until 2008.  He also co-founded NimbleGen Systems, Inc., a molecular biology tools company, and served as its chairman of the board from 1999 to 2007 and as its chief executive officer from 1999 to 2000.  Since their inception, Mr. Palay has served as a manager of the general partner or manager of each of the various Tactics II entities, which are private investment vehicles and are among our principal shareholders.  He received a A.B., magna cum laude, from Harvard College, an M.M. from the J.L. Kellogg Graduate School of Management and a J.D. from the Northwestern University School of Law.   

Dr. Palay is one of our founders and has served as Vice Chairman of the Board and as President since 2007.  Dr. Palay previously served as vice chairman of the board and president of each of our predecessors from their founding until 2008.  He also co-founded NimbleGen Systems, Inc. and served as its vice chairman of the board, vice president and chief operating officer from 1999 to 2007.  Since their inception, Dr. Palay has served as a manager of the general partner or manager of each of the Tactics II entities.  Dr. Palay joined the faculty of the University of Wisconsin Law School in 1980.  He retired as the Foley & Lardner–Bascom Professor of Law in 2010.  Dr. Palay received a B.A., summa cum laude, from Tufts University, a J.D. from the University of Pennsylvania and a Ph.D. from the University of Pennsylvania. 

Mr. Falk has served on our board of directors since 2010 and as general counsel for WARF, the patent management and licensing organization for the University of Wisconsin-Madison, since 2007.  At WARF, Mr. Falk oversees the legal and intellectual property professionals and is part of WARF’s executive management team.  He also serves on the foundation’s investment risk committee.  Before joining WARF, Mr. Falk practiced as a patent litigator with Foley & Lardner LLP.  He received a B.A. from Columbia University and a J.D., an MBA and a MS in microbiology from the University of Wisconsin-Madison. 

Dr. January is one of our founders and has served on our board of directors since 2008.  Since 1981, he has served as a practicing cardiologist and, since 1995, a professor in the Department of Medicine in the Division of Cardiovascular Medicine at the University of Wisconsin-Madison, School of Medicine and Public Health.  Dr. January has consulted to multiple large and small pharmaceutical companies and was one of the first scientists to stably express hERG potassium channels in a human cell system.  He received an MD and a Ph.D. in Physiology and Biophysics from the University of Iowa.   

Mr. Hunt has served on our board of directors since 2009.  He has also served as senior vice president, general counsel and secretary of ManpowerGroup Inc., a world leader in the employment services industry, from 2008 until January 2013.  Prior to joining ManpowerGroup, Mr. Hunt was a shareholder at Godfrey & Kahn, S.C. from 1981 to 2007.  He received a degree in Aerospace Engineering from the University of Michigan and a J.D., with distinction, from Duke University Law School. 

Mr. Lynch has served on our board of directors since 2009.  At Michael Best & Friedrich LLP, Mr. Lynch led the venture capital practice from 2005 to 2010 and the corporate group from 2010 to the present.  Mr. Lynch has over 15 years' experience advising high-growth companies on strategic financing, operational and corporate governance matters from start-up through sale or initial public offering.  He received a BSBA in Finance and Economics from Creighton University and J.D. from the University of Iowa, where he achieved Order of the Coif distinction. 

Dr. Rose has served on our board of directors since 2009.  Dr. Rose has served as president of Rose Ventures, Inc., a Wisconsin-based firm that provides consulting services and makes investments in life science tool companies, since its founding in 2008.  Dr. Rose has served as director of Invenra since 2012 and as director since 2009 and as chief commercial officer since 2011 of Nabsys, a portfolio company of Point Judith Capital.  He also served as president, chief executive officer and a member of the board of directors of NimbleGen Systems, Inc. from 2003 to 2007, continuing on until 2008 as chief executive officer of Roche NimbleGen following Roche's acquisition of NimbleGen Systems, Inc. in 2007.  Prior to NimbleGen Systems, Inc., Dr. Rose co-founded Genetic MicroSystems, a microarray instruments company, in 1997.  Dr. Rose received a B.A. from Cornell University and a Ph.D. in Biology from the Massachusetts Institute of Technology. 

Mr. Van Handel has served on our board of directors since 2010.  He has also served on the board of directors of the Milwaukee Youth Symphony Orchestra since 2005 and BMO Financial Corp. since 2011.  He previously served on the board of directors of Harris Financial Corp. from 2006 to 2011.  Mr. Van Handel has served as a vice president, since 1991, and the chief financial officer, since 1998, of ManpowerGroup Inc.  Mr. Van Handel received a B.S. in Accounting from Marquette University and an MBA in Banking and Finance from the University of Wisconsin.